Michigan Heart

The trials here

What the 9 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation3 trials
• Coronary artery disease2 trials
• Heart failure2 trials
• High blood pressure1 trial
• Stroke1 trial
• Ventricular tachycardia1 trial

Phase

• Phase 41 trial

Status

• Active, not recruiting6 trials
• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Medtronic3 trials
• Heart Rhythm Clinical and Research Solutions, LLC2 trials
• Brigham and Women's Hospital1 trial
• Orchestra BioMed, Inc1 trial
• Population Health Research Institute1 trial
• and 1 more

Running trials

• Active, not recruiting

  Real-world Safety and Effectiveness Registry of Catheter Ablation of Paroxysmal Atrial Fibrillation as Initial Control Therapy With the Thermocool SmartTouch SF Catheter (A Sub-study of REAL AF Registry)

  NCT07092774· Heart Rhythm Clinical and Research Solutions, LLC· Source

• Recruiting

  BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

  NCT06059638· Orchestra BioMed, Inc· Source

  Contact: Steven J. Evans, MD

• Active, not recruiting

  Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)

  NCT04496518· Medtronic· Source

• Active, not recruiting

  Personalized Therapy Study - HFRS (TriageHF) Post Approval Study

  NCT04489225· Medtronic· Source

• Recruiting

  Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias

  NCT04088071· Heart Rhythm Clinical and Research Solutions, LLC· Source

  Contact: Elizabeth Goetz

• Active, not recruiting

  Personalized Therapy Study - Attain Stability Quad Post-Approval Study

  NCT04024943· Medtronic· Source

• Active, not recruiting

  PRE-DETERMINE Cohort Study

  NCT01114269· Brigham and Women's Hospital· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation1 recruiting

Closed trials

• Completed

  PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

  NCT03168776· Sino Medical Sciences Technology Inc.· Source

• Completed

  Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

  NCT01938248· Phase 4· Population Health Research Institute· Source